Variants of insulin-signaling inhibitor genes in type 2 diabetes and related metabolic abnormalities

International Journal of Genomics

Volumn 2013, Issue , 2013, Pages

  De Lorenzo, Carlo ^a   Greco, Annalisa ^a   Fiorentino, Teresa Vanessa ^a   Mannino, Gaia Chiara ^a   Hribal, Marta Letizia ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN SIGNALING INHIBITOR; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN SH2; UNCLASSIFIED DRUG;

GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 84878725463     PISSN: 2314436X     EISSN: 23144378     Source Type: Journal    
DOI: 10.1155/2013/376454     Document Type: Review

References (112)

1. Pessin J. E., Saltiel A. R., Signaling pathways in insulin action: molecular targets of insulin resistance. The Journal of Clinical Investigation 2000 106 2 165 169 2-s2.0-0033913213 (Pubitemid 30483117)
2. Sesti G., Pathophysiology of insulin resistance. Best Practice and Research: Clinical Endocrinology and Metabolism 2006 20 4 665 679 2-s2.0-33845244172 10.1016/j.beem.2006.09.007 (Pubitemid 44856489)
3. Goldfine I. D., Maddux B. A., Youngren J. F., Reaven G., Accili D., Trischitta V., Vigneri R., Frittitta L., The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocrine Reviews 2008 29 1 62 75 2-s2.0-39149099952 10.1210/er.2007-0004 (Pubitemid 351252747)
4. Hashimoto N., Feener E. P., Zhang W. R., Goldstein B. J., Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen- related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. The Journal of Biological Chemistry 1992 267 20 13811 13814 2-s2.0-0026643477
5. Seely B. L., Staubs P. A., Reichart D. R., Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 1996 45 10 1379 1385 10.2337/diabetes.45.10.1379 (Pubitemid 26332902)
6. Pesesse X., Deleu S., de Smedt F., Drayer L., Erneux C., Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochemical and Biophysical Research Communications 1997 239 3 697 700 2-s2.0-0031590449 10.1006/bbrc.1997.7538 (Pubitemid 27504164)
7. Du K., Herzig S., Kulkarni R. N., Montminy M., TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003 300 5625 1574 1577 2-s2.0-0038242819 10.1126/science.1079817 (Pubitemid 36682889)
8. Lebovitz H. E., Insulin resistance-a common link between type 2 diabetes and cardiovascular disease. Diabetes, Obesity and Metabolism 2006 8 3 237 249 2-s2.0-33645474277 10.1111/j.1463-1326.2005.00521.x
9. Prudente S., Morini E., Trischitta V., Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nature Reviews Endocrinology 2009 5 12 682 693 2-s2.0-70749139756 10.1038/nrendo.2009.215
10. Kwak S. H., Park K. S., Genetics of type 2 diabetes and potential clinical implications. Archives of Pharmacal Research 2013 36 2 167 177 10.1007/s12272-013-0021-x
11. Maddux B. A., Chang Y. N., Accili D., McGuinness O. P., Youngren J. F., Goldfine I. D., Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. American Journal of Physiology-Endocrinology and Metabolism 2006 290 4 E746 E749 2-s2.0-33646078811 10.1152/ajpendo.00298.2005
12. Gijsbers R., Ceulemans H., Bollen M., Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1. The Biochemical Journal 2003 371 2 321 330 2-s2.0-0037627479 10.1042/BJ20021943 (Pubitemid 36547614)
13. Costanzo B. V., Trischitta V., Di Paola R., Spampinato D., Pizzuti A., Vigneri R., Frittitta L., The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 2001 50 4 831 836 2-s2.0-0035080028 (Pubitemid 32242641)
14. Di Paola R., Caporarello N., Marucci A., Dimatteo C., Iadicicco C., del Guerra S., Prudente S., Sudano D., Miele C., Parrino C., Piro S., Beguinot F., Marchetti P., Trischitta V., Frittitta L., ENPP1 affects insulin action and secretion: evidences from in vitro studies. PLoS ONE 2011 6 5, article e19462 2-s2.0-79955872917 10.1371/journal.pone.0019462
15. Baratta R., Rossetti P., Prudente S., Barbetti F., Sudano D., Nigro A., Farina M. G., Pellegrini F., Trischitta V., Frittitta L., Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 2008 57 12 3360 3364 2-s2.0-58149354288 10.2337/db07-1830
16. Pizzuti A., Frittitta L., Argiolas A., Baratta R., Goldfine I. D., Bozzali M., Ercolino T., Scarlato G., Iacoviello L., Vigneri R., Tassi V., Trischitta V., A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 1999 48 9 1881 1884 2-s2.0-0032857338 10.2337/diabetes.48.9.1881 (Pubitemid 29415213)
17. Abate N., Carulli L., Cabo-Chan A., Chandalia M., Snell P. G., Grundy S. M., Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. The Journal of Clinical Endocrinology and Metabolism 2003 88 12 5927 5934 2-s2.0-0347993139 10.1210/jc.2003-030453 (Pubitemid 38033074)
18. Abate N., Chandalia M., Satija P., Adams-Huet B., Grundy S. M., Sandeep S., Radha V., Deepa R., Mohan V., ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 2005 54 4 1207 1213 2-s2.0-15944371462 10.2337/diabetes.54.4.1207 (Pubitemid 40446338)
19. Baratta R., Di Paola R., Spampinato D., Fini G., Marucci A., Coco A., Vigneri R., Frittitta L., Trischitta V., Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPAR γ 2 (P12A) polymorphisms. Journal of Molecular Medicine 2003 81 11 718 723 2-s2.0-0344944629 10.1007/s00109-003-0466-3 (Pubitemid 37491597)
20. Frittitta L., Baratta R., Spampinato D., Di Paola R., Pizzuti A., Vigneri R., Trischitta V., The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance. The Journal of Clinical Endocrinology and Metabolism 2001 86 12 5888 5891 2-s2.0-0035217903 10.1210/jc.86.12.5888 (Pubitemid 33152640)
21. González-Sánchez J. L., Martínez-Larrad M. T., Fernández-Pérez C., Kubaszek A., Laakso M., Serrano-Ríos M., K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population. Obesity Research 2003 11 5 603 605 10.1038/oby.2003.86 (Pubitemid 41151609)
22. Gu H. F., Almgren P., Lindholm E., Frittitta L., Pizzuti A., Trischitta V., Groop L. C., Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes 2000 49 9 1601 1603 2-s2.0-0033863689
23. Hamaguchi K., Terao H., Kusuda Y., Yamashita T., Bahles J. A. H., Cruz LL. M. M., Brugal L. I., Jongchong B., Yoshimatsu H., Sakata T., The PC-1 Q121 allele is exceptionally prevalent in the Dominican Republic and is associated with type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 2004 89 3 1359 1364 2-s2.0-12144289924 10.1210/jc.2003-031387 (Pubitemid 38368437)
24. Kubaszek A., Pihlajamäki J., Karhapää P., Vauhkonen I., Laakso M., The K121Q polymorphism of the PC-1 gene is associated with insulin resistance but not with dyslipidemia. Diabetes Care 2003 26 2 464 467 2-s2.0-0041808862 10.2337/diacare.26.2.464 (Pubitemid 36929074)
25. Kubaszek A., Markkanen A., Eriksson J. G., Forsen T., Osmond C., Barker D. J. P., Laakso M., The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth. The Journal of Clinical Endocrinology and Metabolism 2004 89 5 2044 2047 2-s2.0-2442473839 10.1210/jc.2003-031350 (Pubitemid 38619831)
26. Tasic I., Milojkovic M., Sunder-Plassmann R., Lazarevic G., Tasic N. M., Stefanovic V., The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart disease. Clinica Chimica Acta 2007 377 1-2 237 242 2-s2.0-33845426384 10.1016/j.cca.2006.10.003 (Pubitemid 44908257)
27. Bacci S., Ludovico O., Prudente S., Zhang Y. Y., Di Paola R., Mangiacotti D., Rauseo A., Nolan D., Duffy J., Fini G., Salvemini L., Amico C., Vigna C., Pellegrini F., Menzaghi C., Doria A., Trischitta V., The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes 2005 54 10 3021 3025 2-s2.0-25844490514 10.2337/diabetes.54.10.3021 (Pubitemid 41401102)
28. Bochenski J., Placha G., Wanic K., Malecki M., Sieradzki J., Warram J. H., Krolewski A. S., New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 2006 55 9 2626 2630 2-s2.0-33750595696 10.2337/db06-0191 (Pubitemid 44871165)
29. Meyre D., Bouatia-Naji N., Tounian A., Samson C., Lecoeur C., Vatin V., Ghoussaini M., Wachter C., Hercberg S., Charpentier G., Patsch W., Pattou F., Charles M. A., Tounian P., Clément K., Jouret B., Weill J., Maddux B. A., Goldfine I. D., Walley A., Boutin P., Dina C., Froguel P., Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nature Genetics 2005 37 8 863 867 2-s2.0-23044493861 10.1038/ng1604 (Pubitemid 41077112)
30. Matsuoka N., Patki A., Tiwari H. K., Allison D. B., Johnson S. B., Gregersen P. K., Leibel R. L., Chung W. K., Association of K121Q polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American adults. International Journal of Obesity 2006 30 2 233 237 2-s2.0-32544443794 10.1038/sj.ijo.0803132 (Pubitemid 43237676)
31. El Achhab Y., Meyre D., Bouatia-Naji N., Berraho M., Deweirder M., Vatin V., Delplanque J., Serhier Z., Lyoussi B., Nejjari C., Froguel P., Chikri M., Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population. Diabetes & Metabolism 2009 35 1 37 42 2-s2.0-60649110640 10.1016/j.diabet.2008.06.005
32. McAteer J. B., Prudente S., Bacci S., Lyon H. N., Hirschhorn J. N., Trischitta V., Florez J. C., The ENPP1 K121Q polymorphism is associated with type 2 diabetes in european populations evidence from an updated meta-analysis in 42,042 subjects. Diabetes 2008 57 4 1125 1130 2-s2.0-42449116149 10.2337/db07-1336
33. Zeggini E., Scott L. J., Saxena R., Voight B. F., Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genetics 2008 40 5 638 645 2-s2.0-42349106044 10.1038/ng.120 (Pubitemid 351601209)
34. Frayling T. M., Wiltshire S., Hitman G. A., Walker M., Levy J. C., Sampson M., Groves C. J., Menzel S., McCarthy M. I., Hattersley A. T., Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. Diabetes 2003 52 7 1857 1863 2-s2.0-0037677524 (Pubitemid 36792479)
35. Moore A. F., Jablonski K. A., Mason C. C., McAteer J. B., Arakaki R. F., Goldstein B. J., Kahn S. E., Kitabchi A. E., Hanson R. L., Knowler W. C., Florez J. C., The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. The Journal of Clinical Endocrinology and Metabolism 2009 94 2 449 455 2-s2.0-59749097689 10.1210/jc.2008-1583
36. Müssig K., Heni M., Thamer C., Kantartzis K., MacHicao F., Stefan N., Fritsche A., Haring H. U., Staiger H., The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention. Diabetologia 2010 53 3 504 509 2-s2.0-77949262297 10.1007/s00125-009-1612-4
37. Maranghi M., Prudente S., D'Erasmo L., The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals. Nutrition, Metabolism, and Cardiovascular Diseases 2012 10.1016/j.numecd.2011.11.003
38. Prudente S., Chandalia M., Morini E., Baratta R., Dallapiccola B., Abate N., Fzrittitta L., Trischitta V., The Q121/Q121 genotype of ENPP1/PC-1 is associated with lower BMI in non-diabetic whites. Obesity 2007 15 1 1 4 2-s2.0-33846881568 (Pubitemid 46219776)
39. Wan C., Zhang T., Wang B., Obesity risk associated with the K121Q polymorphism of the glycoprotein PC-1 gene. Diabetes, Obesity & Metabolism 2006 8 6 703 708 10.1111/j.1463-1326.2006.00583.x (Pubitemid 44515569)
40. Böttcher Y., Körner A., Reinehr T., ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. The Journal of Clinical Endocrinology and Metabolism 2006 91 12 4948 4952 10.1210/jc.2006-0540 (Pubitemid 44917332)
41. Bacci S., Di Paola R., Menzaghi C., Di Fulvio P., Di Silvestre S., Pellegrini F., Baratta R., Marucci A., Mastroianno S., Fini G., Formoso G., Consoli A., Perticone F., Frittitta L., Pandolfi A., Trischitta V., ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 10 1678 1683 2-s2.0-70349574150 10.1161/ATVBAHA.109. 189191
42. Endler G., Mannhalter C., Sunder-Plassmann H., Schillinger M., Klimesch A., Exner M., Kapiotis S., Meier S., Kunz F., Raiger E., Huber K., Wagner O., Sunder-Plassmann R., The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction. Journal of Molecular Medicine 2002 80 12 791 795 2-s2.0-0036460730 10.1007/s00109-002-0385- 8 (Pubitemid 35478127)
43. Bacci S., Rizza S., Prudente S., Spoto B., Powers C., Facciorusso A., Pacilli A., Lauro D., Testa A., Zhang Y. Y., Di Stolfo G., Mallamaci F., Tripepi G., Xu R., Mangiacotti D., Aucella F., Lauro R., Gervino E. V., Hauser T. H., Copetti M., De Cosmo S., Pellegrini F., Zoccali C., Federici M., Doria A., Trischitta V., The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes 2011 60 3 1000 1007 2-s2.0-79952392468 10.2337/db10-1300
44. Lyon H. N., Florez J. C., Bersaglieri T., Saxena R., Winckler W., Almgren P., Lindblad U., Tuomi T., Gaudet D., Zhu X., Cooper R., Ardlie K. G., Daly M. J., Altshuler D., Groop L., Hirschhorn J. N., Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes 2006 55 11 3180 3184 2-s2.0-33845428756 10.2337/db06-0407 (Pubitemid 44923659)
45. Frittitta L., Ercolino T., Bozzali M., Argiolas A., Graci S., Santagati M. G., Spampinato D., Di Paola R., Cisternino C., Tassi V., Vigneri R., Pizzuti A., Trischitta V., A cluster of three single nucleotide polymorphisms in the 3'-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities. Diabetes 2001 50 8 1952 1955 2-s2.0-0035434678 (Pubitemid 33641619)
46. Chagnon M. J., Uetani N., Tremblay M. L., Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochemistry and Cell Biology 2004 82 6 664 675 2-s2.0-16844386333 10.1139/o04-120 (Pubitemid 40486145)
47. Zabolotny J. M., Kim Y. B., Peroni O. D., Kim J. K., Pani M. A., Boss O., Klaman L. D., Kamatkar S., Shulman G. I., Kahn B. B., Neel B. G., Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5187 5192 2-s2.0-0035942161 10.1073/pnas.071050398 (Pubitemid 32397104)
48. Kulas D. T., Zhang W. R., Goldstein B. J., Furlanetto R. W., Mooney R. A., Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. The Journal of Biological Chemistry 1995 270 6 2435 2438 2-s2.0-0028816605 10.1074/jbc.270.6.2435
49. Ahmad F., Considine R. V., Goldstein B. J., Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. The Journal of Clinical Investigation 1995 95 6 2806 2812 2-s2.0-0029018196
50. Ahmad F., Azevedo J. L., Cortright R., Dohm G. L., Goldstein B. J., Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. The Journal of Clinical Investigation 1997 100 2 449 458 2-s2.0-0030840724 (Pubitemid 27349093)
51. Miscio G., Tassi V., Coco A., Soccio T., Di Paola R., Prudente S., Baratta R., Frittitta L., Ludovico O., Padovano L., Dallapiccola B., Di Mario U., De Cosmo S., Trischitta V., The allelic variant of LAR gene promoter -127 bp T→A is associated with reduced risk of obesity and other features related to insulin resistance. Journal of Molecular Medicine 2004 82 7 459 466 2-s2.0-3843097204 (Pubitemid 39044285)
52. Menzaghi C., Paroni G., de Bonis C., Coco A., Vigna C., Miscio G., Lanna P., Tassi V., Bacci S., Trischitta V., The protein tyrosine phosphatase receptor type f (PTPRF) locus is associated with coronary artery disease in type 2 diabetes. Journal of Internal Medicine 2008 263 6 653 654 2-s2.0-43549108301 10.1111/j.1365-2796.2008.01924.x (Pubitemid 351678583)
53. Norris K., Norris F., Kono D. H., Vestergaard H., Pedersen O., Theofilopoulos A. N., Møller N. P. H., Expression of protein-tyrosine phosphatases in the major insulin target tissues. The FEBS Letters 1997 415 3 243 248 2-s2.0-0030869203 10.1016/S0014-5793(97)01133-2 (Pubitemid 27451941)
54. Chagnon M. J., Elchebly M., Uetani N., Dombrowski L., Cheng A., Mooney R. A., Marette A., Tremblay M. L., Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma. Canadian Journal of Physiology and Pharmacology 2006 84 7 755 763 2-s2.0-33845423553 10.1139/Y06-020 (Pubitemid 44897896)
55. Långberg E. C., Gu H. F., Nordman S., Efendic S., Ostenson C. G., Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians. European Journal of Endocrinology/European Federation of Endocrine Societies 2007 157 4 459 464 10.1530/EJE-07-0114 (Pubitemid 350018449)
56. Tsai F. J., Yang C. F., Chen C. C., Chuang L. M., Lu C. H., Chang C. T., Wang T. Y., Chen R. H., Shiu C. F., Liu Y. M., Chang C. C., Chen P., Chen C. H., Fann C. S. J., Chen Y. T., Wu J. Y., A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genetics 2010 6 2 2-s2.0-77649214654 10.1371/journal.pgen.1000847 e1000847
57. Chang Y. C., Chiu Y. F., Liu P. H., Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort. Clinical Endocrinology 2012 76 3 365 372 10.1111/j.1365-2265.2011.04175.x
58. Pei Q., Huang Q., Yang G. P., PPAR- γ 2 and PTPRD gene polymorphisms influence type 2 diabetes patients'response to pioglitazone in China. Acta Pharmacologica Sinica 2013 34 2 255 261 10.1038/aps.2012.144
59. Bauer F., Onland-Moret N. C., Charlotte O. M. N., PTPN1 polymorphisms are associated with total and low-density lipoprotein cholesterol. European Journal of Cardiovascular Prevention and Rehabilitation 2010 17 1 28 34 10.1097/HJR.0b013e32832d30c4
60. Bauer F., Onland-Moret N. C., Niehoff A. G., Elbers C. C., Grobbee D. E., Wijmenga C., Van Der Schouw Y. T., No association of PTPN1 polymorphisms with macronutrient intake and measures of adiposity. Obesity 2008 16 12 2767 2771 2-s2.0-58149308615 10.1038/oby.2008.426
61. Bento J. L., Palmer N. D., Mychaleckyj J. C., Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 2004 53 11 3007 3012 10.2337/diabetes.53.11.3007 (Pubitemid 39425929)
62. Palmer N. D., Bento J. L., Mychaleckyj J. C., Langefeld C. D., Campbell J. K., Norris J. M., Haffner S. M., Bergman R. N., Bowden D. W., Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: The Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes 2004 53 11 3013 3019 2-s2.0-7044272587 10.2337/diabetes.53.11.3013 (Pubitemid 39425930)
63. Spencer-Jones N. J., Wang X., Snieder H., Spector T. D., Carter N. D., O'Dell S. D., Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes 2005 54 11 3296 3304 2-s2.0-33644686604 10.2337/diabetes.54.11.3296 (Pubitemid 43334388)
64. Cheyssac C., Lecoeur C., Dechaume A., Bibi A., Charpentier G., Balkau B., Marre M., Froguel P., Gibson F., Vaxillaire M., Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population. BMC Medical Genetics 2006 7, article 44 2-s2.0-33746838041 10.1186/1471-2350-7-44 (Pubitemid 44173072)
65. Burdon K. P., Bento J. L., Langefeld C. D., Campbell J. K., Carr J. J., Wagenknecht L. M., Herrington D. M., Freedman B. I., Rich S. S., Bowden D. W., Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the diabetes heart study. Diabetes 2006 55 3 651 658 2-s2.0-33644789964 (Pubitemid 43348454)
66. Florez J. C., Agapakis C. M., Burtt N. P., Sun M., Almgren P., Råstam L., Tuomi T., Gaudet D., Hudson T. J., Daly M. J., Ardlie K. G., Hirschhorn J. N., Groop L., Altshuler D., Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes 2005 54 6 1884 1891 2-s2.0-20044376516 10.2337/diabetes.54.6.1884 (Pubitemid 40770781)
67. Traurig M., Hanson R. L., Kobes S., Bogardus C., Baier L. J., Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians. Diabetologia 2007 50 5 985 989 2-s2.0-34147099620 10.1007/s00125-007-0611-6 (Pubitemid 46559249)
68. Wanic K., Malecki M. T., Klupa T., Warram J. H., Sieradzki J., Krolewski A. S., Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes. Diabetic Medicine 2007 24 6 650 655 2-s2.0-34249339065 10.1111/j.1464-5491.2007.02132.x (Pubitemid 46808864)
69. Di Paola R., Frittitta L., Miscio G., A variation in 3'UTR of hPTP1B increases specific gene expression and associates with insulin resistance. American Journal of Human Genetics 2002 70 3 806 812 10.1086/339270 (Pubitemid 34177937)
70. Meshkani R., Taghikhani M., Mosapour A., Larijani B., Khatami S., Khoshbin E., Ahmadvand D., Saeidi P., Maleki A., Yavari K., Nasoohi N., Adeli K., 1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population. Archives of Medical Research 2007 38 5 556 562 2-s2.0-34249867959 10.1016/j.arcmed.2007.01.010 (Pubitemid 46873805)
71. Bodhini D., Radha V., Ghosh S., Majumder P. P., Mohan V., Lack of association of PTPN1 gene polymorphisms with type 2 diabetes in south Indians. Journal of Genetics 2011 90 2 323 326 10.1007/s12041-011-0060-3
72. Dahlman I., Wahrenberg H., Persson L., Arner P., No association of reported functional protein tyrosine phosphatase 1B 3′ UTR gene polymorphism with features of the metabolic syndrome in a Swedish population. Journal of Internal Medicine 2004 255 6 694 695 2-s2.0-2542527676 10.1111/j.1365-2796.2004.01341.x (Pubitemid 38703592)
73. Echwald S. M., Bach H., Vestergaard H., Richelsen B., Kristensen K., Drivsholm T., Borch-Johnsen K., Hansen T., Pedersen O., A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 2002 51 1 1 6 2-s2.0-0036094599 (Pubitemid 34517973)
74. Malodobra M., Pilecka A., Gworys B., Adamiec R., Single nucleotide polymorphisms within functional regions of genes implicated in insulin action and association with the insulin resistant phenotype. Molecular and Cellular Biochemistry 2011 349 1-2 187 193
75. Speirs H. J. L., Katyk K., Kumar N. N., Benjafield A. V., Wang W. Y. S., Morris B. J., Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. Journal of Hypertension 2004 22 5 931 936 2-s2.0-2542465907 10.1097/00004872-200405000- 00014 (Pubitemid 38680467)
76. Weng J., Yan J., Huang Z., Sui Y., Xiu L., Missense mutation of Pro387Leu in protein tyrosine phosphatase-1B (PTP-1B) is not associated with type 2 diabetes in a Chinese Han population. Diabetes Care 2003 26 10, article 2957 2-s2.0-0141669144 10.2337/diacare.26.10.2957 (Pubitemid 37205577)
77. Santaniemi M., Ukkola O., Kesäniemi Y. A., Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes. Journal of Internal Medicine 2004 256 1 48 55 2-s2.0-3042636426 10.1111/j.1365-2796.2004. 01339.x (Pubitemid 38813619)
78. Gouni-Berthold I., Giannakidou E., Müller-Wieland D., Faust M., Kotzka J., Berthold H. K., Krone W., The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population. Journal of Internal Medicine 2005 257 3 272 280 2-s2.0-14844321913 10.1111/j.1365-2796.2004.01446.x (Pubitemid 40342130)
79. Ukkola O., Rankinen T., Lakka T., Leon A. S., Skinner J. S., Wilmore J. H., Rao D. C., Kesäniemi Y. A., Bouchard C., Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism. Obesity Research 2005 13 5 829 834 2-s2.0-24344444907
80. Kipfer-Coudreau S., Eberlé D., Sahbatou M., Bonhomme A., Guy-Grand B., Froguel P., Galan P., Basdevant A., Clément K., Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia 2004 47 7 1278 1284 2-s2.0-4143087179 (Pubitemid 39093324)
81. Mo J., Wu J., Sun Z., Yang H., Lei M., Liu W., Association of PTP1B gene polymorphism with obesity in Chinese children. Journal of Central South University. Medical Sciences 2010 35 9 915 920
82. Mok A., Cao H., Zinman B., Hanley A. J. G., Harris S. B., Kennedy B. P., Hegele R. A., A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in oji-cree. The Journal of Clinical Endocrinology and Metabolism 2002 87 2 724 727 2-s2.0-0036173341 10.1210/jc.87.2.724 (Pubitemid 34158243)
83. Gu P., Jiang W., Du H., Protein tyrosine phosphatase 1B gene polymorphisms and essential hypertension: a case-control study in Chinese population. Journal of Endocrinological Investigation 2010 33 7 483 488
84. Meshkani R., Taghikhani M., Al-Kateb H., Larijani B., Khatami S., Sidiropoulos G. K., Hegele R. A., Adeli K., Polymorphisms within the protein tyrosine phosphatase IB (PTPN1) gene promoter: functional characterization and association with type 2 diabetes and related metabolic traits. Clinical Chemistry 2007 53 9 1585 1592 2-s2.0-34548361384 10.1373/clinchem.2007.088146 (Pubitemid 47340053)
85. Wada T., Sasaoka T., Funaki M., Hori H., Murakami S., Ishiki M., Haruta T., Asano T., Ogawa W., Ishihara H., Kobayashi M., Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity. Molecular and Cellular Biology 2001 21 5 1633 1646 2-s2.0-0035135318 10.1128/MCB.21.5.1633-1646.2001 (Pubitemid 32156383)
86. Sasaoka T., Hori H., Wada T., Ishiki M., Haruta T., Ishihara H., Kobayashi M., SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 2001 44 10 1258 1267 2-s2.0-0034775501 10.1007/s001250100645 (Pubitemid 33010502)
87. Vollenweider P., Clodi M., Martin S. S., Imamura T., Kavanaugh W. M., Olefsky J. M., An SH2 domain-containing 5' inositolphosphatase inhibits insulin- induced GLUT4 translocation and growth factor-induced actin filament rearrangement. Molecular and Cellular Biology 1999 19 2 1081 1091 2-s2.0-0032911883 (Pubitemid 29046851)
88. Clément S., Krause U., Desmedt F., The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 2001 409 6816 92 97 10.1038/35051094 (Pubitemid 32098631)
89. Clément S., Krause U., Desmedt F., Corrigendum: the lipid phosphatase SHIP2 controls insulin sensitivity. Nature 2004 431 7010 878 878
90. Sleeman M. W., Wortley K. E., Lai K. M. V., Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nature Medicine 2005 11 2 199 205 10.1038/nm1178 (Pubitemid 40321356)
91. Xu X., Rogus J. J., Terwedow H. A., Yang J., Wang Z., Chen C., Niu T., Wang B., Xu H., Weiss S., Schork N. J., Fang Z., An extreme-sib-pair genome scan for genes regulating blood pressure. American Journal of Human Genetics 1999 64 6 1694 1701 2-s2.0-0033361891 10.1086/302405 (Pubitemid 30481522)
92. Panhuysen C. I. M., Cupples L. A., Wilson P. W. F., Herbert A. G., Myers R. H., Meigs J. B., A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study. Diabetologia 2003 46 4 579 587 2-s2.0-0037955823 (Pubitemid 36577804)
93. Silander K., Scott L. J., Valle T. T., A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes 2004 53 3 821 829 10.2337/diabetes.53.3.821 (Pubitemid 38270654)
94. Marion E., Kaisaki P. J., Pouillon V., Gueydan C., Levy J. C., Bodson A., Krzentowski G., Daubresse J. C., Mockel J., Behrends J., Servais G., Szpirer C., Kruys V., Gauguier D., Schurmans S., The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 2002 51 7 2012 2017 2-s2.0-0036300603 (Pubitemid 34729002)
95. Kaisaki P. J., Delépine M., Woon P. Y., Sebag-Montefiore L., Wilder S. P., Menzel S., Vionnet N., Marion E., Riveline J. P., Charpentier G., Schurmans S., Levy J. C., Lathrop M., Farrall M., Gauguier D., Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes 2004 53 7 1900 1904 2-s2.0-3042820621 10.2337/diabetes.53.7.1900 (Pubitemid 38857051)
96. Marçano A. C. B., Burke B., Gungadoo J., Wallace C., Kaisaki P. J., Woon P. Y., Farrall M., Clayton D., Brown M., Dominiczak A., Connell J. M., Webster J., Lathrop M., Caulfield M., Samani N., Gauguier D., Munroe P. B., Genetic association analysis of inositol polyphosphate phosphatase-like 1 (INPPL1, SHIP2) variants with essential hypertension. Journal of Medical Genetics 2007 44 9 603 605 2-s2.0-34548825125 10.1136/jmg.2007.049718 (Pubitemid 47441770)
97. Kagawa S., Sasaoka T., Yaguchi S., Ishihara H., Tsuneki H., Murakami S., Fukui K., Wada T., Kobayashi S., Kimura I., Kobayashi M., Impact of Src homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. The Journal of Clinical Endocrinology and Metabolism 2005 90 5 2911 2919 2-s2.0-21044450947 10.1210/jc.2004-1724 (Pubitemid 40686343)
98. Matsushima R., Harada N., Webster N. J. G., Tsutsumi Y. M., Nakaya Y., Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity. The Journal of Biological Chemistry 2006 281 40 29719 29729 2-s2.0-33749554507 10.1074/jbc.M511636200 (Pubitemid 44536981)
99. Liu J., Wu X., Franklin J. L., Messina J. L., Hill H. S., Moellering D. R., Walton R. G., Martin M., Garvey W. T., Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance. American Journal of Physiology-Endocrinology and Metabolism 2010 298 3 E565 E576 2-s2.0-77349107131 10.1152/ajpendo.00467.2009
100. Prudente S., Hribal M. L., Flex E., Turchi F., Morini E., De Cosmo S., Bacci S., Tassi V., Cardellini M., Lauro R., Sesti G., Dallapiccola B., Trischitta V., The functional Q84R polymorphism of mammalian tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 2005 54 9 2807 2811 2-s2.0-24144466446 10.2337/diabetes.54.9.2807 (Pubitemid 41233606)
101. Liew C. W., Bochenski J., Kawamori D., Hu J., Leech C. A., Wanic K., Malecki M., Warram J. H., Qi L., Krolewski A. S., Kulkarni R. N., The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse β cells. The Journal of Clinical Investigation 2010 120 8 2876 2888 2-s2.0-77955284657 10.1172/JCI36849
102. Andreozzi F., Formoso G., Prudente S., Hribal M. L., Pandolfi A., Bellacchio E., Silvestre S. D., Trischitta V., Consoli A., Sesti G., TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1355 1360 2-s2.0-46249084940 10.1161/ATVBAHA.108.162883
103. Prudente S., Scarpelli D., Chandalia M., Zhang Y. Y., Morini E., del Guerra S., Perticone F., Li R., Powers C., Andreozzi F., Marchetti P., Dallapiccola B., Abate N., Doria A., Sesti G., Trischitta V., The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 2009 94 1 190 196 2-s2.0-58149389465 10.1210/jc.2008-1365
104. Prudente S., Baratta R., Andreozzi F., Morini E., Farina M. G., Nigro A., Copetti M., Pellegrini F., Succurro E., Di Pietrantonio L., Brufani C., Barbetti F., Dallapiccola B., Sesti G., Trischitta V., Frittitta L., TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion. Diabetologia 2010 53 7 1354 1361 2-s2.0-77955657265 10.1007/s00125-010-1749-1
105. Kahn C. R., Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes. Experimental Diabesity Research 2003 4 3 169 182 2-s2.0-0345328687 (Pubitemid 37483654)
106. Morini E., Prudente S., Succurro E., Chandalia M., Zhang Y. Y., Mammarella S., Pellegrini F., Powers C., Proto V., Dallapiccola B., Cama A., Sesti G., Abate N., Doria A., Trischitta V., IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants. Diabetologia 2009 52 9 1852 1857 2-s2.0-68449104737 10.1007/s00125-009-1426-4
107. Bacci S., Prudente S., Copetti M., Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. Atherosclerosis 2013 226 1 140 145 10.1016/j.atherosclerosis.2012. 10.035
108. Doria A., Patti M. E., Kahn C. R., The emerging genetic architecture of type 2 diabetes. Cell Metabolism 2008 8 3 186 200 2-s2.0-50049086521 10.1016/j.cmet.2008.08.006
109. Grarup N., Andersen G., Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 4 420 426 2-s2.0-34250616639 10.1097/MCO.0b013e3281e2c9ab (Pubitemid 46934110)
110. Cornelis M. C., Tchetgen E. J. T., Liang L., Gene-environment interactions in genome-wide association studies: a comparative study of tests applied to empirical studies of type 2 diabetes. American Journal of Epidemiology 2012 175 3 191 202 10.1093/aje/kwr368
111. Metzker M. L., Sequencing technologies-the next generation. Nature Reviews Genetics 2010 11 1 31 46 2-s2.0-72849144434 10.1038/nrg2626
112. McCarthy M. I., Rorsman P., Gloyn A. L., TCF7L2 and diabetes: a tale of two tissues, and of two species. Cell Metabolism 2013 17 2 157 159 10.1016/j.cmet.2013.01.011